Financial

Financial
21/07/2021

Oncodesign announces a sharp increase in turnover in the first half of 2021

Group turnover up by 33% at €15.8M. Despite the global health crisis, which continues to limit international travel...

Corporate
Financial
05/07/2021

Oncodesign announces the appointment of Aline Aubertin as an independent director of the Board of Directors

Oncodesign strenghens its Board by appointing Aline Aubertin as new independent director.

SOLO-Pharmaco-Imaging
Service
Financial
28/06/2021

Oncodesign launches its new DRIVE-MRT™ service offer in partnership with Covalab, CheMatech and ABX-CRO

[Press Release] Explore our brand new service offer DRIVE-MRT. it allows the rationalization, design and optimization of targeted radiopharmaceutical products that are effective against certain metastatic cancers.

Biotech
Financial
24/06/2021

Oncodesign provides an update on its progress on RIPK2

[Press Release] Find the update of the RIPK2 program and the start of new programs associated with Nanocyclix.

Financial Result oncodesign
Financial
18/06/2021

Oncodesign maintains its revenue and operating income at €38 million in 2020…

[Press Release] Oncodesign maintains its revenue and operating income at €38 million in 2020 and is anticipating an operating profit for the 2nd straight year, within the context of the global public health crisis